Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Detection of ASD at the 1st Birthday as Standard of Care: The Get SET Early Model

27 de febrero de 2020 actualizado por: Karen Pierce, University of California, San Diego
According to a recent report from the Centers for Disease Control, most children with ASD do not receive a diagnosis and begin receiving treatment until well after their 4th birthday, which is unfortunate given that many connections between brain cells have already been established by that age. This program will test a model called Get S.E.T. Early (S=Screen, E=Evaluate, T=Treat) in both San Diego and Phoenix, designed to detect, evaluate, and treat ASD within the first 2 years of life. In this proposal 7,500 toddlers from the general population will be screened in San Diego and Phoenix (total 15,000) using the CSBS IT Checklist (Wetherby & Prizant, 2002) at well baby check-ups using a "triple screen" approach wherein toddlers are screened at three ages starting at 12 months. Investigators predict that providing screening tools with clear cut-off scores and guidelines for automatic referral for both evaluation and treatment will result in dramatically lowering mean age of detection in Phoenix from 4-5 years down to 1-2 years. Investigators also predict that using repeat screening at 12, 18, & 24 months in combination with automatic referral options via technology (i-Pads) will result in an increase in the number of ASD toddlers detected by 24 months relative to a single time point screen using traditional paper screens.

Descripción general del estudio

Estado

Desconocido

Descripción detallada

Investigators previously demonstrated that their early intervention model system, which was centered on using the CSBS IT Checklist to screen all babies at the 1-year check-up as standard of care, resulted in a mean age of 12 months for screening, 14 months for evaluation, and 18 months for treatment participation. These are far younger ages than is common in the U.S. The 3-stage model system, Get SET (S=Screen; E=Evaluate; T=Treat) Early, screened >10,000 1 year olds in the first trial run detecting over 100 ASD and other developmental delayed toddlers. The current grant will build on this highly effective model by implementing a new version in two major cities: San Diego and Phoenix; data mined from electronic records from Kaiser pediatric offices in Los Angeles and Irvine will provide control data. In Phoenix, investigators test the feasibility of establishing the Get SET Early model in a city with one of the lowest median incomes and oldest age of first diagnosis in America. In AIM #1, the Screen and Refer Early stage, investigators will create a Pediatrician Network with 100 members in Phoenix. In San Diego investigators will utilize their existing Pediatrician Network and test new innovations such as a repeat "triple screen" at 12, 18, and 24 months to ensure that no toddlers are missed. Speed of referral for evaluation will be compared and contrasted using parent (self) and automatic (referral i-Pad App) options. Investigators will track every toddler with an eventual ASD diagnosis within circumscribed medical groups to determine the true sensitivity and specificity of the screening tool and the percentage of ASD toddlers detected by this model. Anonymous survey data regarding screening habits will be administered to parents and pediatricians. AIM #2 implements the Evaluate and Refer Early stage. Its key attribute is an ASD Early Evaluation Clinic that specializes in the rapid scheduling and evaluation of every referred screened positive toddler. Toddlers will enter the program at the age they fail the screen (i.e., 12, 18 or 24 months) and will be thoroughly diagnostically evaluated and tracked once per year until they turn 3 years. This specialty Clinic is at the Autism Center in San Diego and will be developed at SARRC in Phoenix. Automated versus optional self-referral for treatment will be tested and compared. AIM #3 implements the Treat Early stage. Its key attributes are a network of providers of empirically based treatment and the innovative use of an inexpensive and readily available web-based treatment tracking system to document engagement. Treatment Networks will be created in San Diego and Phoenix. Primary outcome measures include rates and ages of screening and referral, evaluation and referral, and treatment engagement; sustainability across years; diagnostic, clinical and demographic characteristics of subjects; professional and parent satisfaction at each stage. Investigators hypothesize that providing screening tools with clear cut-off scores and guidelines for automatic referral for evaluation and treatment, will result in dramatically lowering mean age of diagnosis and treatment in Phoenix from 4-5 years down to 1-2 years; San Diego will likewise have mean ages of 1-2 years for diagnosis and treatment making them significantly earlier than non-intervention contrast cities.

Tipo de estudio

De observación

Inscripción (Anticipado)

12000

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Mallory Barrett
  • Número de teléfono: 858-822-3613
  • Correo electrónico: mpiazzola@ucsd.edu

Copia de seguridad de contactos de estudio

  • Nombre: Elizabeth Bacon
  • Número de teléfono: 858-534-6910
  • Correo electrónico: ebacon@ucsd.edu

Ubicaciones de estudio

    • Arizona
      • Phoenix, Arizona, Estados Unidos, 85006
        • Reclutamiento
        • Southwest Autism Research & Resource Center (Sarrc)
        • Contacto:
        • Sub-Investigador:
          • Christopher Smith, PhD
    • California
      • La Jolla, California, Estados Unidos, 92037
        • Reclutamiento
        • Autism Center of Excellence
        • Contacto:
          • Mallory Barrett
          • Número de teléfono: 858-822-3613
          • Correo electrónico: mpiazzola@ucsd.edu
        • Contacto:
          • Elizabeth Bacon
          • Número de teléfono: 858-534-6910
          • Correo electrónico: ebacon@ucsd.edu
        • Investigador principal:
          • Karen Pierce, PhD

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

1 año a 3 años (Niño)

Acepta Voluntarios Saludables

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra de probabilidad

Población de estudio

Two cohorts of toddlers, those in San Diego and Phoenix, will participate. Toddlers in both cities from the general population will be screened for ASD and other delays using the CSBS Infant-Toddler Checklist in pediatric offices at the 12, 18, and 24 month well-baby visits.

Descripción

Inclusion Criteria:

  • Completed CSBS IT Checklist at pediatrician office
  • Pediatrician referred
  • Between 12 and 36 months

Exclusion Criteria:

  • Older than 36 months

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
San Diego, CA
Toddlers detected with ASD and other disorders based on the Get SET Early Model in San Diego.
Phoenix, AZ
Toddlers detected with ASD and other disorders based on the Get SET Early Model in Phoenix.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Periodo de tiempo
Rate of screening per pediatric office
Periodo de tiempo: Year 4
Year 4
Rate of referral for developmental evaluation per pediatric office
Periodo de tiempo: Year 4
Year 4
Age at screen
Periodo de tiempo: Year 4
Year 4
Age at developmental evaluation
Periodo de tiempo: Year 4
Year 4
Age at treatment start
Periodo de tiempo: Age at treatment start will be tracked for 4 years, and an average age computed in year 5
Age at treatment start will be tracked for 4 years, and an average age computed in year 5
Number of ASD toddlers detected by program
Periodo de tiempo: Year 4
Year 4
Changes in parent and pediatrician screening perceptions from baseline to Year 4
Periodo de tiempo: Year 5
Year 5

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Karen Pierce, PhD, University of California, San Diego

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de agosto de 2014

Finalización primaria (Anticipado)

1 de junio de 2020

Finalización del estudio (Anticipado)

1 de junio de 2020

Fechas de registro del estudio

Enviado por primera vez

27 de mayo de 2015

Primero enviado que cumplió con los criterios de control de calidad

1 de junio de 2015

Publicado por primera vez (Estimar)

4 de junio de 2015

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

2 de marzo de 2020

Última actualización enviada que cumplió con los criterios de control de calidad

27 de febrero de 2020

Última verificación

1 de febrero de 2020

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • R01MH104446 (Subvención/contrato del NIH de EE. UU.)

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

3
Suscribir